Continuing Medical Education
The Center for Continuing Education is committed to sharing a wealth of knowledge with physicians, nurses, and other medical professionals worldwide for more than 80 years. Its objective is to provide high-quality, innovative educational programs that increase the knowledge of health care providers, resulting in improved patient outcomes.
Upcoming Event
2nd Annual Cleveland Clinic Cancer Conference: Innovations in Multidisciplinary Care
January 16-18, 2026 | Hollywood, FL
This program will provide disease specific, evidence-based, high quality and practical talks and exchanges to update the participants on the latest advances in the diagnosis and multidisciplinary management of the most prevalent cancers at all stages of disease and treatment.
The conference will cater to medical oncologists, hematologists, radiation oncologists, and other healthcare professionals involved in the diagnosis, prevention and treatment of cancer. Current, new and future advances in cancer care will be discussed. The role of emerging technologies, supportive care and non-pharmacologic care of the cancer patient will be addressed. In addition to didactic lectures, case-based discussions will address the more challenging situations faced by cancer caregivers.
American Society of Clinical Oncology (ASCO)
Featured Abstracts from the 2025 Annual Meeting
- First-Ever U.S. Trial of CAR T-Cell Therapy for Relapsed/Refractory AL Amyloidosis
- Exploring Novel Therapeutic Avenues in Advanced Cholangiocarcinoma: Lessons from the EA2187 Trial
- Direct-Acting Oral Anticoagulants Safe for Patients with Brain Metastasis
- Novel Targeted Treatment for NSCLC Effective Across Multiple Regions and Populations
- Adjuvant Immunotherapy in High-Risk Cutaneous Squamous Cell Carcinoma
American Society for Radiation Oncology (ASTRO)
Featured Abstracts from the 2024 Annual Meeting
- ASTRO 2024 Highlights
- New Study Supports SBRT as Safe, Effective for Osteosarcoma
- One-Time Screening for Nasopharyngeal Cancer Among High-Risk Populations in the U.S. May Reduce Cancer Mortality
- Partial Breast Irradiation Delivered Daily Well Tolerated in Patients with Early-Stage Breast Cancer
- When to Pursue More Aggressive Treatment for Patients with T1-2a Cutaneous Squamous Cell Carcinoma
- Five Years of Parallel Prospective Plan of Care Reviews
American Society of Hematology (ASH)
Featured Abstracts from the 2024 Annual Meeting
- Looking Forward: Advances and Obstacles in Blood Cancer Treatment
- Major Study Finds CAR T-Cell Therapy Safe and Effective for Older Patients With B-Cell Acute Lymphoblastic Leukemia
- Access Barriers to Transplant Affect Outcomes in AML
- Real-World Study Examines Optimal Sequencing and Timing of Treatments for Relapsed/Refractory Multiple Myeloma
- Bispecific Antibody Glofitamab Combination with Chemoimmunotherapy Safe and Effective for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma after Initial Therapy
- Efficacy and Safety Outcomes of Bispecific Antibodies
